Point72 Asset Management, L.P. 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 1,643,844 1.700% | -4,637,801![]() (-73.83%) | Filing |
2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 6,281,645 6.700% | 1,615,538![]() (+34.62%) | Filing |
2022-02-10 5:07 pm Purchase | 2022-01-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 4,666,107 5.000% | 4,666,107![]() (New Position) | Filing |